Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Malignant Female Reproductive System Neoplasm × Laparotomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 4 Uterine Cervical Neoplasms 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Burkitt Lymphoma 1

Interventions

Laparotomy 1 Hydromorphone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04258631 2024-10-16

Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies

Mayo Clinic

Phase 4 Completed

105 enrolled 22 charts

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡